Our Team
Geoff Meyerson
Managing Director and Co-Founder
Geoff brings a track record of success in investment banking, venture capital and licensing where he has closed >25 transactions of all varieties. While an investment banker in UBS' Global Healthcare Investment Banking Group, he closed 12 financing and M&A transactions with a variety of life science companies. Geoff worked at MedImmune in business development working on their small molecule strategy, which resulted in three transactions, assisted with two other transactions. While a venture capitalist at SR One, the venture capital subsidiary of GlaxoSmithKline, he closed eight transactions in the US and Europe, co-leading the due diligence for Algeta, which concluded an $800M partnership with Bayer leading to a 6x return to investors. Geoff worked in business development at Zelos Therapeutics negotiating a drug delivery collaboration with Aegis Therapeutics. He brings strong deal acumen, business and financial strategy, and negotiation capabilities. Geoff was named by the Philadelphia Business Journal to their 40 Under Forty list for 2010. He holds an MBA in Health Care Management from the Wharton School, a Master of Biotechnology from the University of Pennsylvania, and a BS in Economics from Duke University
 |
|
 |
|
 |
|
